Since supplementation of retinoids may be helpful in patients with hepatitis C virus-related HCC, the vital part of treatment may be the activation of RARα and therefore up-regulation of TFPI-2 [130]. The gene discussed is RARA; the disease is hepatocellular carcinoma.